BNT162b1

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT162b1, covering 2023-09-18 to 2023-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects [Phase 1]